Söllner W, Zingg-Schir M, Rumpold G, Fritsch P
Department of Medical Psychology and Psychotherapy, Leopold Franzens University, Innsbruck, Austria.
Arch Dermatol. 1997 Mar;133(3):316-21. doi: 10.1001/archderm.1997.03890390054007.
To examine the attitude of patients with melanoma toward alternative therapies, their compliance with standard treatment, social support received by them, and their ways of coping with illness.
Survey in a representative sample.
University hospital; central melanoma clinic serving Tyrol region in Austria.
Two hundred thirty-six consecutive patients with melanoma were approached in a 3-month-period, and 215 of them participated in the study.
Results of a self-developed questionnaire to record patients' interest in alternative therapies, the Hornheide Questionnaire to assess patients' distress and social support, and the Freiburg Questionnaire of Coping With Illness.
One hundred seventeen patients (54.4%) reported interest in nonconventional therapy. Thirty (14%) patients admitted actual use of such methods. The latter group more often suffered from advanced cancer (P < .001). Compared with uninterested patients, subjects interested in alternative therapy were younger (95% confidence intervals [CI] = 41.3-46.5 vs 48.7-56.7; P < .001), showed a more active coping style (95% CIs = 3.45-3.75 vs 2.91-3.50; P = .001) and a tendency toward religiousness and search for personal meaning in the disease (95% CIs = 2.56-2.85 vs 2.17-2.64; P < or = .08). Their faith in conventional medicine and ready compliance with physicians' suggestions were not less than those of uninterested patients (95% CIs = 4.26-4.46 vs 4.35- 4.64; P = .25). However, they believed that they were receiving less emotional support from their physicians (95% CIs = 0.95-1.74 vs 0.21-0.93; P = .04) and expressed interest in getting more such support (P = .04).
Patients with melanoma consider non-conventional therapies as supplementary to standard medical methods and as a way of avoiding passivity and coping with feelings of hopelessness. This does not lessen the need to educate patients about the lack of efficacy of unorthodox methods but stresses the importance of offering them adequate emotional support.
研究黑色素瘤患者对替代疗法的态度、他们对标准治疗的依从性、所获得的社会支持以及应对疾病的方式。
对具有代表性样本进行调查。
大学医院;奥地利蒂罗尔地区的中央黑色素瘤诊所。
在3个月期间,连续接触了236例黑色素瘤患者,其中215例参与了研究。
一份自行编制的问卷结果,用于记录患者对替代疗法的兴趣;霍恩海德问卷,用于评估患者的痛苦程度和社会支持情况;以及弗赖堡应对疾病问卷。
117例患者(54.4%)表示对非常规疗法感兴趣。30例(14%)患者承认实际使用过此类方法。后一组患者更常患有晚期癌症(P <.001)。与不感兴趣的患者相比,对替代疗法感兴趣的受试者更年轻(95%置信区间[CI]=41.3 - 46.5对48.7 - 56.7;P <.001),表现出更积极的应对方式(95% CI = 3.45 - 3.75对2.91 - 3.50;P =.001),并且有宗教倾向以及在疾病中寻求个人意义的趋势(95% CI = 2.56 - 2.85对2.17 - 2.64;P ≤.08)。他们对传统医学的信任以及对医生建议的依从性并不低于不感兴趣的患者(95% CI = 4.26 - 4.46对4.35 - 4.64;P =.25)。然而,他们认为从医生那里得到的情感支持较少(95% CI = 0.95 - 1.74对0.21 - 0.93;P =.04),并表示希望获得更多此类支持(P =.04)。
黑色素瘤患者将非常规疗法视为标准医疗方法的补充,以及一种避免消极被动和应对绝望情绪的方式。这并未减少向患者宣传非正统方法缺乏疗效的必要性,但强调了为他们提供充分情感支持的重要性。